| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |